The South Korean government has introduced regulations requiring cigarette manufacturers to strengthen health warnings on cigarette packaging starting in late December.
The Ministry of Health and Welfare will distribute the updated manual for labeling health warnings on cigarette packaging as a follow-up to the government's tobacco industry regulation revision passed in June.
The new regulation is to take effect on Dec. 23.
The manual requires cigarette manufacturers to include more graphic warnings on their products. A warning about second-hand smoking, for example, includes a rendered image of a newborn child sucking on a baby bottle stuffed with cigarette butts.
According to officials, e-cigarettes will be required to have health warnings on more than half of their packaging.


Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



